Breaking News

580,000 Monkeypox Vaccines Have Shipped in the USA

August 5, 2022 • 12:20 pm CDT
from Pixabay
(Precision Vaccinations)

The U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) announced today that more than​ 602,000​ ​doses of Bavarian Nordic’s Jynneos vaccine were available in the USA.

Jynneos is a U.S. FDA-licensed vaccine (2019) indicated for the prevention of smallpox and monkeypox.

As of August 3, 2022, deliveries from the U.S. Strategic National Stockpile to jurisdictions to support their local monkeypox vaccination response efforts had reached 580,733.

The SNS began shipping doses of Jynneos on May 21.

The majority of Jynneos distributions have been to California, New York, and Florida.

The good news is vaccine supplies will significantly increase in the months ahead.

On July 15, 2022, ASPR announced that it had ordered an additional 2.5 million doses of Jynneos vaccines.

This order will bring the federal government’s ​available supply to more than 6.9 million doses by mid-​2023. 

And to better update the general public, HHS previously announced an enhanced national strategy to vaccinate and protect at-risk individuals from monkeypox infections by prioritizing Jynneos for areas with the highest number of cases.

Furthermore, the U.S. government named leaders to execute its monkeypox outbreak initiatives on August 2.

Robert Fenton is now the White House National Monkeypox Response Coordinator, and Dr. Demetre Daskalakis is the White House National Monkeypox Response Deputy Coordinator.

Additional monkeypox vaccine news is posted at PrecisionVaccinations.com/Monkeypox.

Share